(6PSK) Invesco FTSE RAFI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B23D9570
6PSK: Emerging, Markets, Equity, Shares, Companies
The Invesco FTSE RAFI Emerging Markets UCITS ETF (XETRA: 6PSK) is an exchange-traded fund that tracks the Morningstar EM TME NR USD index, providing investors with exposure to a diversified portfolio of emerging markets equities. The fund is listed on the XETRA exchange and is domiciled in Germany.
The ETFs investment strategy is based on a fundamentally-weighted approach, using the FTSE RAFI methodology, which selects and weights constituents based on fundamental measures such as sales, cash flow, dividends, and book value. This approach is designed to reduce the impact of overvalued stocks and increase exposure to undervalued ones.
From a technical analysis perspective, the ETFs price is currently above its 20-day, 50-day, and 200-day simple moving averages (SMA20, SMA50, and SMA200), indicating a positive trend. The average true range (ATR) is 0.18, representing 2.07% of the current price, suggesting moderate volatility. Given the current technical setup, with the price above its SMAs and relatively low volatility, a potential forecast is that the ETF will continue its upward trend, potentially reaching the upper end of its 52-week range.
Combining technical and fundamental analysis, we can forecast that the ETFs assets under management (AUM) are likely to increase if the emerging markets equities continue to perform well, attracting more investors to the fund. With an AUM of 34.10M EUR, the fund has a relatively small but still significant presence in the market. As the ETF tracks a broad emerging markets index, its performance is closely tied to the overall trend in emerging markets equities. If the fundamental outlook for emerging markets remains positive, we can expect the ETFs price to continue to rise, potentially reaching new highs.
Based on the available data, a potential price target for the ETF could be around 9.00, representing a 2.15% increase from the current price. This forecast is based on the ETFs current technical setup and the assumption that the emerging markets equities will continue to perform well. However, its essential to continuously monitor the ETFs performance and adjust the forecast accordingly.
Additional Sources for 6PSK ETF
6PSK ETF Overview
Market Cap in USD | 39m |
Category | Global Emerging Markets Equity |
TER | 0.49% |
IPO / Inception | 2007-11-12 |
6PSK ETF Ratings
Growth Rating | 61.4 |
Fundamental | - |
Dividend Rating | 56.0 |
Rel. Strength | -13.9 |
Analysts | - |
Fair Price Momentum | 8.63 EUR |
Fair Price DCF | - |
6PSK Dividends
Dividend Yield 12m | 3.88% |
Yield on Cost 5y | 6.12% |
Annual Growth 5y | 8.41% |
Payout Consistency | 75.7% |
Payout Ratio | % |
6PSK Growth Ratios
Growth Correlation 3m | -19.7% |
Growth Correlation 12m | 62.4% |
Growth Correlation 5y | 74.1% |
CAGR 5y | 11.08% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | -0.21 |
Alpha | -0.28 |
Beta | 0.515 |
Volatility | 15.94% |
Current Volume | 0.7k |
Average Volume 20d | 5.1k |
As of June 06, 2025, the stock is trading at EUR 8.68 with a total of 748 shares traded.
Over the past week, the price has changed by -0.17%, over one month by +1.53%, over three months by -0.89% and over the past year by +12.96%.
Yes. Based on ValueRay´s Analyses, Invesco FTSE RAFI Emerging (XETRA:6PSK) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 61.38 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of 6PSK is around 8.63 EUR . This means that 6PSK is currently overvalued and has a potential downside of -0.58%.
Invesco FTSE RAFI Emerging has no consensus analysts rating.
According to our own proprietary Forecast Model, 6PSK Invesco FTSE RAFI Emerging will be worth about 9.7 in June 2026. The stock is currently trading at 8.68. This means that the stock has a potential upside of +11.64%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 9.7 | 11.6% |